Risk Factors for Diagnosis of Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis, and Ankylosing Spondylitis : A Set of Parallel Case-control Studies

• Published in: The Journal of Rheumatology
• Main Authors: Meer, Elana, Thrastardottir, Telma, Wang, Xingmei, Dubreuil, Maureen, Chen, Yong, Gelfand, Joel M., Love, Thorvardur J., Ogdie, Alexis
• Other Authors: Faculty of Medicine, Other departments
• Format: Article in Journal/Newspaper
• Language: English
• Published: 2022
• Subjects: Gigtarlæknisfræði; ankylosing spondylitis; epidemiology; psoriasis; psoriatic arthritis; rheumatoid arthritis; risk factors; Arthritis; Psoriatic/diagnosis; Humans; Spondylitis; Ankylosing/diagnosis; Case-Control Studies; Rheumatoid/diagnosis; Rheumatology; Immunology and Allergy; Immunology; Iceland
• Online Access: https://hdl.handle.net/20.500.11815/3801; https://doi.org/10.3899/jrheum.210006

Funding Information: This work was supported in part by the National Institutes of Health (NIH), Grant K23 AR063764, to the principal investigator AO, and internal funds from the University of Pennsylvania. MD was supported by the NIH, Grant K23 AR06912701. 1E. Meer, BA, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; 2T. Thrastardottir, MPH, T.J. Love, MD, PhD, Department of Medicine/Rheumatology, University of Iceland and Landspitali, Reykjavik, Iceland; 3X. Wang, MD, Y. Chen, PhD, Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; 4M. Dubreuil, MD, Department of Medicine/Rheumatology, Boston University, Boston, Massachusetts, USA; 5J.M. Gelfand, MD, MSCE, Department of Biostatistics, Epidemiology and Informatics, and Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; 6A. Ogdie, MD, MSCE, Department of Biostatistics, Epidemiology and Informatics, and Department of Medicine/ Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. JMG has served as a consultant for BMS, Boehringer Ingelheim, Lilly, Janssen Biologics, Novartis, UCB (DSMB), Neuroderm (DSMB), Dr. Reddy’s Labs, Pfizer, and Sun Pharma, receiving honoraria; receives research grants (to the Trustees of the University of Pennsylvania) from AbbVie, Boehringer Ingelheim, Janssen, Novartis, Celgene, Ortho Dermatologics, and Pfizer; and received payment for continuing medical education work related to psoriasis that was supported indirectly by Lilly, Ortho Dermatologics, and Novartis. JMG is a co-patent holder of resiquimod for treatment of cutaneous T-cell lymphoma, is a Deputy Editor for the Journal of Investigative Dermatology, receiving honoraria from the Society for Investigative Dermatology, and is a member of the Board of Directors for the International Psoriasis Council, receiving no honoraria. TJL ...